Ron Grossman, MD, FRCPC, FACP, FCCP, University of Toronto, Toronto, ON
Moderator: Clare Ramsey, MD, MSc, FRCPC, University of Manitoba, Winnipeg, MB
This talk will cover identification of features suggesting poorly controlled asthma and its consequences. The latest treatment paradigms will be discussed. Differentiation of currently available agents will be covered and new therapeutic options, particularly the addition of inhaled antimuscarinics, will be reviewed.
At the end of this presentation, attendees will be able to:
- Detect features that suggest poor asthma control;
- Recognize the consequences of poorly controlled asthma;
- Identify new treatment paradigms for asthma; and
- Appreciate new treatment options in the management of moderate-to-severe asthma.
CanMEDS Roles Addressed: Communicator, Health Advocate, Leader, Medical Expert, Professional, Scholar
This session is co-developed by the Canadian Thoracic Society and Valeo Pharma and is planned to achieve scientific integrity, objectivity and balance.